Insights On Outsourced Drug Development
-
Key Factors To Consider When Selecting A Stereo Microscope
1/8/2024
Explore a comprehensive guide to choosing the right stereo microscope for your application, including which key factors you should consider and analyze.
-
Acceleratorâ„ Virtual Reality Training
9/20/2022
The Accelerator Virtual Reality (VR) Training Center offers instant, scalable access to training programs for a wide variety of Pall® technology without the constraints of trainer and equipment availability.
-
Engineering Advances In Needle Geometry To Accommodate Viscous Biologics
2/1/2023
Explore the challenges faced in administering highly viscous biologics to patients via subcutaneous injection and how new special thin-wall needles are able to tackle them.
-
The Flux Performance Of Nanoformed And Untreated PRX Solid Suspensions
7/26/2023
Explore the application of in vitro flux assays to nanoparticles, with data on how the in vitro permeability apparatus can characterize the membrane flux performance of an API formulated as a nanosuspension.
-
Analysis Of Drug-Excipient Incompatibility In Discovery And Formulation Development
3/7/2024
We analyze drug-excipient incompatibility using a microcalorimeter system equipped with a multi-sample cell capable of simultaneously measuring highly sensitive heat flow data from up to three samples.
-
Lowering The Lipids Barrier: The Key To Accelerating RNA-LNP Drug Development
12/27/2023
Learn about the drug development hurdles that must be overcome to deliver on the promise of mRNA.
-
The Importance Of Recording Zero In The Digital Age
4/9/2024
Explore the value of negative results and how proper data management enables your digital maturity journey towards scientific advancement.
-
The Key To HPAPI Manufactuting Success
3/1/2024
Watch to explore a training center dedicated to the development and manufacturing of HPAPIs that is setting a new industry standard for safety and expertise.
-
A Versatile Application For Rapid Mass Confirmation And Purity Assessment Of Biotherapeutics
7/18/2022
We explore a streamlined integrated workflow for data acquisition, processing and reporting of deconvoluted mass data for biotherapeutics, deployable in regulated and non-regulated environments.
-
Managing Poor Solubility With Cutting-Edge Formulation Approaches
8/24/2022
An increasing number of poorly soluble APIs are the cornerstone of cutting-edge therapies, necessitating equally complex formulation technologies to maintain or improve solubility and, ultimately, bioavailability.